Selected research
Industry Research
Galantamine Tablets Industry Research Report 2026
Market perspective
The global Galantamine Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Galantamine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Galantamine Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Galantamine Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Galantamine Tablets include Zhejiang Jinhua CONBA Bio-Pharm, YiChang HEC ChangJiang Pharmaceutical, Yabao Pharmaceutical, Sinopharm, Zydus, Sun Pharma, Sandoz, Hikma and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Galantamine Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Galantamine Tablets Market by Company
Zhejiang Jinhua CONBA Bio-Pharm
YiChang HEC ChangJiang Pharmaceutical
Yabao Pharmaceutical
Sinopharm
Zydus
Sun Pharma
Sandoz
Hikma
Dr. Reddy's Laboratories
Barr Pharmaceuticals
Aurobindo Pharma
Galantamine Tablets Segment by Type
Extended-release Tablets
Orally Disintegrating Tablets
Immediate-release Tablets
Galantamine Tablets Segment by Application
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Galantamine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galantamine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Galantamine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galantamine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Galantamine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Galantamine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Galantamine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Extended-release Tablets
- Orally Disintegrating Tablets
- Immediate-release Tablets
Applications
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Companies covered
- Zhejiang Jinhua CONBA Bio-Pharm
- YiChang HEC ChangJiang Pharmaceutical
- Yabao Pharmaceutical
- Sinopharm
- Zydus
- Sun Pharma
- Sandoz
- Hikma
- Dr. Reddy's Laboratories
- Barr Pharmaceuticals
- Aurobindo Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Galantamine Tablets Market Size (2021-2032)
- 2.2.2 Global Galantamine Tablets Sales (2021-2032)
- 2.2.3 Global Galantamine Tablets Market Average Price (2021-2032)
- 2.3 Galantamine Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Extended-release Tablets
- 2.3.3 Orally Disintegrating Tablets
- 2.3.4 Immediate-release Tablets
- 2.4 Galantamine Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacy
- 2.4.3 Hospital Pharmacy
- 2.4.4 Online Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Galantamine Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Galantamine Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Galantamine Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Galantamine Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Galantamine Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Galantamine Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Galantamine Tablets, Product Type & Application
- 3.8 Global Manufacturers of Galantamine Tablets, Established Date
- 3.9 Global Galantamine Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Jinhua CONBA Bio-Pharm
- 4.1.1 Zhejiang Jinhua CONBA Bio-Pharm Company Information
- 4.1.2 Zhejiang Jinhua CONBA Bio-Pharm Business Overview
- 4.1.3 Zhejiang Jinhua CONBA Bio-Pharm Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Jinhua CONBA Bio-Pharm Galantamine Tablets Product Portfolio
- 4.1.5 Zhejiang Jinhua CONBA Bio-Pharm Recent Developments
- 4.2 YiChang HEC ChangJiang Pharmaceutical
- 4.2.1 YiChang HEC ChangJiang Pharmaceutical Company Information
- 4.2.2 YiChang HEC ChangJiang Pharmaceutical Business Overview
- 4.2.3 YiChang HEC ChangJiang Pharmaceutical Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 YiChang HEC ChangJiang Pharmaceutical Galantamine Tablets Product Portfolio
- 4.2.5 YiChang HEC ChangJiang Pharmaceutical Recent Developments
- 4.3 Yabao Pharmaceutical
- 4.3.1 Yabao Pharmaceutical Company Information
- 4.3.2 Yabao Pharmaceutical Business Overview
- 4.3.3 Yabao Pharmaceutical Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Yabao Pharmaceutical Galantamine Tablets Product Portfolio
- 4.3.5 Yabao Pharmaceutical Recent Developments
- 4.4 Sinopharm
- 4.4.1 Sinopharm Company Information
- 4.4.2 Sinopharm Business Overview
- 4.4.3 Sinopharm Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sinopharm Galantamine Tablets Product Portfolio
- 4.4.5 Sinopharm Recent Developments
- 4.5 Zydus
- 4.5.1 Zydus Company Information
- 4.5.2 Zydus Business Overview
- 4.5.3 Zydus Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zydus Galantamine Tablets Product Portfolio
- 4.5.5 Zydus Recent Developments
- 4.6 Sun Pharma
- 4.6.1 Sun Pharma Company Information
- 4.6.2 Sun Pharma Business Overview
- 4.6.3 Sun Pharma Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sun Pharma Galantamine Tablets Product Portfolio
- 4.6.5 Sun Pharma Recent Developments
- 4.7 Sandoz
- 4.7.1 Sandoz Company Information
- 4.7.2 Sandoz Business Overview
- 4.7.3 Sandoz Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sandoz Galantamine Tablets Product Portfolio
- 4.7.5 Sandoz Recent Developments
- 4.8 Hikma
- 4.8.1 Hikma Company Information
- 4.8.2 Hikma Business Overview
- 4.8.3 Hikma Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hikma Galantamine Tablets Product Portfolio
- 4.8.5 Hikma Recent Developments
- 4.9 Dr. Reddy's Laboratories
- 4.9.1 Dr. Reddy's Laboratories Company Information
- 4.9.2 Dr. Reddy's Laboratories Business Overview
- 4.9.3 Dr. Reddy's Laboratories Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr. Reddy's Laboratories Galantamine Tablets Product Portfolio
- 4.9.5 Dr. Reddy's Laboratories Recent Developments
- 4.10 Barr Pharmaceuticals
- 4.10.1 Barr Pharmaceuticals Company Information
- 4.10.2 Barr Pharmaceuticals Business Overview
- 4.10.3 Barr Pharmaceuticals Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Barr Pharmaceuticals Galantamine Tablets Product Portfolio
- 4.10.5 Barr Pharmaceuticals Recent Developments
- 4.11 Aurobindo Pharma
- 4.11.1 Aurobindo Pharma Company Information
- 4.11.2 Aurobindo Pharma Business Overview
- 4.11.3 Aurobindo Pharma Galantamine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Aurobindo Pharma Galantamine Tablets Product Portfolio
- 4.11.5 Aurobindo Pharma Recent Developments
5 Global Galantamine Tablets Market Scenario by Region
- 5.1 Global Galantamine Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Galantamine Tablets Sales by Region: 2021-2032
- 5.2.1 Global Galantamine Tablets Sales by Region: 2021-2026
- 5.2.2 Global Galantamine Tablets Sales by Region: 2027-2032
- 5.3 Global Galantamine Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Galantamine Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Galantamine Tablets Revenue by Region: 2027-2032
- 5.4 North America Galantamine Tablets Market Facts & Figures by Country
- 5.4.1 North America Galantamine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Galantamine Tablets Sales by Country (2021-2032)
- 5.4.3 North America Galantamine Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Galantamine Tablets Market Facts & Figures by Country
- 5.5.1 Europe Galantamine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Galantamine Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Galantamine Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Galantamine Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Galantamine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Galantamine Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Galantamine Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Galantamine Tablets Market Facts & Figures by Country
- 5.7.1 South America Galantamine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Galantamine Tablets Sales by Country (2021-2032)
- 5.7.3 South America Galantamine Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Galantamine Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Galantamine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Galantamine Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Galantamine Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Galantamine Tablets Sales by Type (2021-2032)
- 6.1.1 Global Galantamine Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Galantamine Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Galantamine Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Galantamine Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Galantamine Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Galantamine Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Galantamine Tablets Sales by Application (2021-2032)
- 7.1.1 Global Galantamine Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Galantamine Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Galantamine Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Galantamine Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Galantamine Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Galantamine Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Galantamine Tablets Value Chain Analysis
- 8.1.1 Galantamine Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Galantamine Tablets Production Mode & Process
- 8.2 Galantamine Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Galantamine Tablets Distributors
- 8.2.3 Galantamine Tablets Customers
9 Global Galantamine Tablets Analyzing Market Dynamics
- 9.1 Galantamine Tablets Industry Trends
- 9.2 Galantamine Tablets Industry Drivers
- 9.3 Galantamine Tablets Industry Opportunities and Challenges
- 9.4 Galantamine Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst